NM_032531.4:c.1995C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032531.4(KIRREL3):​c.1995C>T​(p.Gly665Gly) variant causes a synonymous change. The variant allele was found at a frequency of 0.636 in 1,604,440 control chromosomes in the GnomAD database, including 327,436 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.67 ( 34316 hom., cov: 35)
Exomes 𝑓: 0.63 ( 293120 hom. )

Consequence

KIRREL3
NM_032531.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.21

Publications

16 publications found
Variant links:
Genes affected
KIRREL3 (HGNC:23204): (kirre like nephrin family adhesion molecule 3) The protein encoded by this gene is a member of the nephrin-like protein family. These proteins are expressed in fetal and adult brain, and also in podocytes of kidney glomeruli. The cytoplasmic domains of these proteins interact with the C-terminus of podocin, also expressed in the podocytes, cells involved in ensuring size- and charge-selective ultrafiltration. The protein encoded by this gene is a synaptic cell adhesion molecule with multiple extracellular immunoglobulin-like domains and a cytoplasmic PDZ domain-binding motif. Mutations in this gene are associated with several neurological and cognitive disorders. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
ST3GAL4 (HGNC:10864): (ST3 beta-galactoside alpha-2,3-sialyltransferase 4) This gene encodes a member of the glycosyltransferase 29 family, a group of enzymes involved in protein glycosylation. The encoded protein is targeted to Golgi membranes but may be proteolytically processed and secreted. The gene product may also be involved in the increased expression of sialyl Lewis X antigen seen in inflammatory responses. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 11-126424922-G-A is Benign according to our data. Variant chr11-126424922-G-A is described in ClinVar as [Benign]. Clinvar id is 129425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.884 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIRREL3NM_032531.4 linkc.1995C>T p.Gly665Gly synonymous_variant Exon 17 of 17 ENST00000525144.7 NP_115920.1 Q8IZU9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIRREL3ENST00000525144.7 linkc.1995C>T p.Gly665Gly synonymous_variant Exon 17 of 17 1 NM_032531.4 ENSP00000435466.2 Q8IZU9-1
KIRREL3ENST00000529097.6 linkc.1959C>T p.Gly653Gly synonymous_variant Exon 16 of 16 1 ENSP00000434081.2 E9PRX9
ST3GAL4ENST00000524834.5 linkn.630-15264G>A intron_variant Intron 6 of 6 2

Frequencies

GnomAD3 genomes
AF:
0.668
AC:
101646
AN:
152066
Hom.:
34299
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.719
Gnomad AMI
AF:
0.563
Gnomad AMR
AF:
0.627
Gnomad ASJ
AF:
0.781
Gnomad EAS
AF:
0.906
Gnomad SAS
AF:
0.649
Gnomad FIN
AF:
0.647
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.629
Gnomad OTH
AF:
0.677
GnomAD2 exomes
AF:
0.661
AC:
162630
AN:
245874
AF XY:
0.660
show subpopulations
Gnomad AFR exome
AF:
0.720
Gnomad AMR exome
AF:
0.591
Gnomad ASJ exome
AF:
0.779
Gnomad EAS exome
AF:
0.908
Gnomad FIN exome
AF:
0.645
Gnomad NFE exome
AF:
0.633
Gnomad OTH exome
AF:
0.664
GnomAD4 exome
AF:
0.633
AC:
919027
AN:
1452256
Hom.:
293120
Cov.:
64
AF XY:
0.634
AC XY:
456527
AN XY:
720542
show subpopulations
African (AFR)
AF:
0.724
AC:
24054
AN:
33224
American (AMR)
AF:
0.590
AC:
26165
AN:
44310
Ashkenazi Jewish (ASJ)
AF:
0.776
AC:
20114
AN:
25936
East Asian (EAS)
AF:
0.889
AC:
35077
AN:
39472
South Asian (SAS)
AF:
0.647
AC:
55663
AN:
85980
European-Finnish (FIN)
AF:
0.645
AC:
34242
AN:
53112
Middle Eastern (MID)
AF:
0.681
AC:
3909
AN:
5738
European-Non Finnish (NFE)
AF:
0.616
AC:
680936
AN:
1104542
Other (OTH)
AF:
0.648
AC:
38867
AN:
59942
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
20756
41512
62268
83024
103780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18468
36936
55404
73872
92340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.668
AC:
101714
AN:
152184
Hom.:
34316
Cov.:
35
AF XY:
0.671
AC XY:
49937
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.719
AC:
29859
AN:
41532
American (AMR)
AF:
0.627
AC:
9591
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.781
AC:
2711
AN:
3470
East Asian (EAS)
AF:
0.906
AC:
4678
AN:
5166
South Asian (SAS)
AF:
0.649
AC:
3129
AN:
4824
European-Finnish (FIN)
AF:
0.647
AC:
6857
AN:
10592
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.629
AC:
42758
AN:
67986
Other (OTH)
AF:
0.678
AC:
1431
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1773
3546
5320
7093
8866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.654
Hom.:
23851
Bravo
AF:
0.668
Asia WGS
AF:
0.730
AC:
2539
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
9.7
DANN
Benign
0.82
PhyloP100
4.2
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs948052; hg19: chr11-126294817; COSMIC: COSV69386762; COSMIC: COSV69386762; API